en · de · es · fr · pt
melanotan-2-notes.peptides6579.com › Faq › Chemistry And Receptor Pharmacology — Beginner to Advanced

Chemistry And Receptor Pharmacology — Beginner to Advanced

By Editorial Desk · published 2026-02-09 · last reviewed 2026-03-11 · Faq

This is a working overview of alpha-MSH analog, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-03-11. Anything still debated is marked as such rather than presented as settled.

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan-2 Structure and Receptor Pharmacology

No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Cyclic heptapeptide, C-terminally amidated
Approximate molecular mass1024 DaMonoisotopic mass of the free peptide
AppearanceWhite to off-white powderTypically supplied as a lyophilised solid
Solubility classSoluble in water and polar solventsAlso dissolves in neutral aqueous buffer
Common synonymsMelanotan II, MT-II, MT-2Described as a melanocortin agonist in early literature

Background and Mechanism of Melanotan-2

Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.

Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.

Related pages on this site

Melanotan-2 Identity and Receptor Pharmacology

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.

Origins and Research Status

Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.

Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.

Reference notes

Itopride increases acetylcholine concentrations by inhibiting dopamine D2 receptors and acetylcholinesterase. Higher acetylcholine increases GI peristalsis, increases the lower esophageal sphincter pressure, stimulates gastric motility, accelerates gastric emptying, and improves gastro-duodenal coordination. Itopride given as a single dose study found that it also raises levels of motilin, somatostatin and lowers levels of cholecystokinin, as well as adrenocorticotropic hormone. These effects may also contribute to itopride's pharmacology.

By the time of nominations closing in April 2026, however, Galloway was no longer standing as a constituency candidate in Glasgow Southside, though remained on the regional ballot. He was unsuccessful, as were all other Workers Party candidates in the election. On 27 September 2025, while returning from Moscow through Abu Dhabi, George Galloway and his wife Putri Gayatri Pertiwi were stopped and questioned at Gatwick Airport by the Metropolitan Police's Counter Terrorism Command under the Counter-Terrorism and Border Security Act 2019 and questioned on his opinions of Russia, and China. His party condemned this as "politically motivated intimidation". The Metropolitan Police said "Neither of them were arrested and they were allowed on their way". Following the arrest Galloway entered a "self-imposed exile" in Russia. On the 4 September 2026, the Bank of Scotland closed Galloway's account prompting him to condemn the bank on X, saying "I will not stand by while you use your usurious power to wreck my family life." on the matter. In preparation for the 2026 Greater Manchester mayoral by-election, Galloway announced his candidacy on 19 June 2026. However, when nominations were released on 6 July, he was not listed as a candidate and was not included on the ballot. On the 14 September 2026 George Galloway announced his intention to stand in the 2026 Holborn and St. Pancras by-election on his podcast, MOATS.

subphylum Anthozoa Ehrenberg, 1834 class Hexacorallia Haeckel, 1896 — stony corals class Octocorallia Haeckel, 1866 — soft corals and sea fans subphylum Endocnidozoa Zrzavý & Hypša, 2003 — parasites class Myxozoa Grassé, 1970 class Polypodiozoa Raikova, 1994 subphylum Medusozoa Petersen, 1979 class Cubozoa Werner, 1973 — box jellies class Hydrozoa Owen, 1843 — hydrozoans (fire corals, hydroids, hydroid jellyfishes, siphonophores...) class Scyphozoa Goette, 1887 — "true" jellyfishes class Staurozoa Marques & Collins, 2004 — stalked jellyfishes

=== HLX === Following the release of Half-Life: Alyx in 2020, dataminers examining updates to the Source 2 engine discovered that Valve was developing a non-VR game codenamed HLX. On December 31, 2024, Mike Shapiro, the voice actor for the G-Man, posted a cryptic message on X suggesting "unexpected surprises" in the new year. In April, it was reported that HLX was being playtested and would be a sequel to Episode Two. Industry insiders, dataminers and leakers reported that Valve was planning a 2025 announcement for HLX. In December, the Insider Gaming senior editor Mike Straw said HLX was planned as a launch game for Valve's Steam Machine hardware, and the announcement had been delayed by the rising cost of RAM.

==== Females ==== Outcomes have generally indicated that early onset of puberty in females can be psychologically damaging. The main reason for this detrimental effect is the issue of body image. As they physically develop, gaining weight in several areas of the body, early-maturing females usually look larger than females who have not yet entered puberty. A result of the social pressure to be thin, the early-maturing females develop a negative view of their body image. In addition, people may tease the females about their visible breasts, forcing the early-maturing female to hide her breasts by dressing differently. Embarrassment about a more developed body may also result in the refusal to undress for gym. These experiences lead to lower self-esteem, more depression and poorer body image in these early-maturing females. Furthermore, as physical and emotional differences set them apart from people in their same age group, early-maturing females develop relationships with older people. For instance, some early-maturing females have older malefriends, "attracted to the females' womanly physique and femaleish innocence." While having an older malefriend might improve popularity among peers, it also increases the risk of alcohol and drug use, increased sexual relations (often unprotected), eating disorders and bullying. Generally, later onset of puberty in females produces positive outcomes. They exhibit positive behaviors in adolescence that continue to adulthood.

Sources: en.wikipedia.org

Reference notes

They organized Manchurian guerrillas against the Russians from the Chinese warlords and bandit chieftains in the region, the most important being Marshal Zhang Zuolin. The Black Dragons waged a very successful psychological warfare campaign in conjunction with the Japanese military, spreading disinformation and propaganda throughout the region. They also acted as interpreters for the Japanese army. The Kokuryūkai assisted the Japanese spy, Colonel Motojiro Akashi. Akashi, who was not directly a member of the Black Dragons, ran successful operations in China, Manchuria, Siberia and established contacts throughout the Muslim world. These contacts in Central Asia were maintained through World War II. The Black Dragons also formed close contact and even alliances with Buddhist sects throughout Asia. During the 1920s and 1930s, the Kokuryūkai evolved into more of a mainstream political organization, and publicly attacked liberal and leftist thought. Although it never had more than several dozen members at any one time during this period, the close ties of its membership to leading members of the government, military and powerful business leaders gave it a power and influence far greater than most other ultranationalist groups. In 1924, retired naval captain Yutaro Yano and his associates within the Black Dragon Society invited Oomoto leader Onisaburo Deguchi on a journey to Mongolia. Onisaburo led a group of Oomoto disciples, including Aikido founder Morihei Ueshiba.

In medieval Europe, early Christian monasteries adopted Roman aquacultural practices. Aquaculture spread because people away from coasts and big rivers were otherwise dependent on fish which required salting in order to be preserved. Fish was an important food source in medieval Europe, when in average 150 days per year were days of fasting and abstinence, and meat was prohibited. Improvements in transportation during the 19th century made fresh fish easily available and inexpensive, even in inland areas, rendering aquaculture less popular. The 15th-century fishponds of the Trebon Basin in the present-day Czech Republic are maintained as a tentative UNESCO World Heritage Site. Samoans practised "a traditional form of giant clam ranching". Hawaiians constructed oceanic fish ponds. A remarkable example is the "Menehune" fishpond dating from at least 1,000 years ago, at Alekoko. Legend records its construction by the mythical Menehune dwarf-people. In the first half of the 18th century, German Stephan Ludwig Jacobi experimented with external fertilization of brown trout and salmon. He wrote an article "Von der künstlichen Erzeugung der Forellen und Lachse" (On the Artificial Production of Trout and Salmon) summarizing his findings, and earning him a reputation as the founder of artificial fish-rearing. By the latter decades of the 18th century, oyster-farming had begun in estuaries along the Atlantic Coast of North America. The word "aquaculture" appeared in an 1855 newspaper article in reference to the harvesting of ice.

The C-terminal precursor DCD-1L is a 48 residue peptide that shows partial helicity in solution, as evidenced by the determination of its solution structure by NMR and CD-spectroscopy. The full length precursor is processed by undetermined proteases present in human sweat, to form several shorter peptides that show variable antimicrobial activity, named according to their C-terminal triplet of amino acids and their residue length. One such active peptide is SSL25, which shows a 2-fold increase in activity against E. coli compared to DCD-1L.

In inhibitory synapses, the opening of either Cl- or K+ channels diminish the probability of depolarization in postsynaptic neurons and the initiation of an action potential. Astrocytes also exchange information with the synaptic neurons, responding to synaptic activity and, in turn, regulating neurotransmission.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

How does melanotan II differ from afamelanotide?

Afamelanotide is the linear analogue [Nle4-D-Phe7]-alpha-MSH, sometimes called melanotan I, while melanotan II is cyclic and carries three further substitutions. The two are distinct molecules and are not interchangeable in analytical testing.

Is the receptor binding profile well established?

Binding to the four melanocortin receptor subtypes is well documented in vitro. The relative contribution of each subtype to whole-body effects in humans is far less certain.

Is melanotan-2 approved for medical use?

No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.

Network